Plerixafor and Clofarabine in Frontline Treatment of Elderly Patients With Acute Myelogenous Leukemia (AML)
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The goal of Part 1 of this clinical research study is to learn about the safety of the
combination of plerixafor and clofarabine when given to patients with previously untreated
AML who are at least 60 years old.
The goal of Part 2 of this study is to learn if the combination of plerixafor and clofarabine
can help to control previously untreated AML in patients who are at least 60 years old. Study
was closed early and did not progress to Part 2.